Followers | 16 |
Posts | 967 |
Boards Moderated | 0 |
Alias Born | 11/16/2021 |

Saturday, May 24, 2025 11:50:02 AM
“HMBL is trash!” typed user jimr1717 for the 117th time this week.
“Delisting any minute now,” chimed in tdbowieknife, proudly screenshotting the Level 2 like it was gospel.
“I have sources,” HuggyBear, who once met a guy whose cousin’s dog walker followed someone who worked at a transfer agent.
Meanwhile, in the land of long-term holders, aka “The Delusional Diamondhands” as the bashers called them, hope was alive but fragile.
Panic spread in the dark corners of the basher forums.
“Is this… retail buying?”
“Wait, who’s pumping this?”
“I’m down 3 iPhones on this short. Somebody call Gary Gensler!”
They scrambled to find a narrative. Bots. Glitches. Solar flares. A butterfly flapping its wings in Brazil. But nothing could explain it.
By noon, $HMBL was up 50% and the only thing stronger than the green candle was the silence from the bashers. They’d retreated to their dens, muttering.
On the long weekend ahead, holders sipped their drinks poolside, phones in one hand, smug grins in the other.
Meanwhile, the bashers?
They were left doing the only thing they could: wait for the long weekend to end.
Because no matter what, that $HMBL 50% send-off was real, it was green, and it was glorious.

Recent HMBL News
- Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 07/09/2025 03:00:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/05/2025 09:30:06 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/09/2025 09:31:33 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 04/30/2025 08:47:31 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 04/18/2025 08:05:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2025 08:34:05 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2025 03:30:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2025 08:10:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2025 10:13:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2025 10:27:27 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 12/26/2024 09:05:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2024 07:25:49 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/20/2024 02:43:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2024 09:05:16 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 12/11/2024 10:21:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/03/2024 03:42:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/19/2024 09:00:38 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2024 11:14:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 04:10:18 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/11/2024 08:35:17 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/30/2024 08:40:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 08:53:54 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2024 08:16:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:05:13 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM